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Abstract OBJECTIVES: The brain and the gut communicate bi-directionally through the 
brain–gut axis. The key role in such interactions plays autonomic nervous system 
and its major component, the vagus nerve. There is growing evidence that vagus 
nerve stimulation (VNS) has a suppressive effect on both short- and long-term 
feeding in animal models. In the present study, we investigated the effect of VNS 
on the hypothalamic pituitary adrenal axis, feeding behavior and appetite in rats 
fed a high-fat diet. 
METHODS: Adult male Wistar rats were implanted with a microstimulator (MS) 
and fed a high-fat diet throughout the study (42 days). The left vagus nerve was 
stimulated subdiaphragmatically by electrical pulses (10 ms, 200 mV, 1 Hz or 10 Hz 
respectively, 12 h a day) generated by the MS. Daily food intake and body weight 
were measured. At the end of the experiment, animals were euthanized and serum 
corticosterone levels were assessed by immunoassays. Adipose tissue content was 
evaluated by measuring epididymal fat pads’ weight. To determine whether VNS 
activated food-related areas of the brain, neuronal c-Fos induction in the nucleus 
of the solitary tract (NTS) was assessed. 
RESULTS: Chronic VNS decreased food intake, body weight gain and epididymal 
fat pad weight in stimulated animals compared to control animals. Serum corti-
costerone concentrations were significantly elevated following VNS, and neuronal 
responses in the NTS were observed.
CONCLUSIONS: The study demonstrates that chronic electrical VNS exerts 
anorexigenic effects on food intake and body weight gain, and the hypothalamic 
pituitary adrenal axis activation may contribute to these effects.
 
INTRODUCTION
The brain and the gut communicate bi-direction-
ally through the brain–gut axis. The key role in 
such interactions plays autonomic nervous system 
and its major component, the vagus nerve (VN). 
VN influences the neuro-endocrine-immune axis 
to maintain homeostasis through the activation of 
the hypothalamic pituitary adrenal (HPA) axis by 
its afferents (Jänig 2008). Stress factors transmitted 
via vagal afferents cause activation of parvocellular 
neurons of the paraventricular nucleus of the hypo-
thalamus and the consequent release of the neuro-
peptides corticotropin releasing hormone (CRH) 
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and arginine vasopressin (AVP) into the hypophyseal 
portal system. CRH and AVP act on corticotrope cells 
of the anterior pituitary gland and stimulate secretion 
of peptides derived from pro-opiomelanocortin which 
include adrenocorticotropin (ACTH), the opioid pep-
tide β-endorphin and α-melanocyte-stimulating hor-
mone. ACTH acts on the cortex of the adrenal glands 
to stimulate the synthesis of glucocorticoids. In humans 
the predominant glucocorticoid is cortisol, whereas in 
rodents the key glucocorticoid is corticosterone. Glu-
cocorticoids are the final effectors of the HPA axis and 
participate in the control of whole body homeosta-
sis and the organism’s response to stress. (Tilbrook & 
Clarke 2006; Tsigos & Chrousos 2002). 
The vagus nerve is the longest of the cranial nerves 
and a main component of the parasympathetic nervous 
system providing innervation of several organs of the 
neck, thorax, and abdomen. The vagal trunk innervat-
ing the gut is composed mainly of unmyelinated fibers 
with afferent fibers being the major component (over 
80%), while vagal efferents represent less than 20%. 
Vagal afferents conduct information to the brain from 
periphery, influencing feeding behavior and diges-
tive reflexes. Vagal efferents originated from neurons 
located in brainstem nuclei – the dorsal motor nucleus 
of the vagus (DMX) and nucleus ambiguus – control 
autonomic functions. The VN regulates heart rate, 
blood pressure, and gastrointestinal motility and secre-
tion (Berthoud & Neuhuber 2000; Prechtl & Powley 
1990). The right VN innervates the sinoatrial node 
(involved in the pacemaker function of the heart), and 
the left VN innervates the atrioventricular node (regu-
lating the force of contraction of the heart muscle with 
less influence over heart rate). Vagus nerve stimulation 
(VNS) of the right nerve, compared to the left, caused 
a greater reduction in heart rate, whereas stimulation 
of the left VN had no effect on heart rate (Woodbury 
& Woodbury 1990). Thus, in experimental as well as 
clinical conditions VNS is performed mainly on the left 
vagus (Bonaz et al. 2013).
The VN afferent neurons are located in the nodose 
ganglions and transmit sensory information to the 
nucleus of the solitary tract (NTS). Nucleus of the 
solitary tract, the dorsal motor nucleus of the vagus 
nerve and the area postrema constitute the dorsal vagal 
complex (DVC), which provide the major integrative 
center for ANS. Consequently, vagus nerve afferents 
to the central nervous system have been examined as 
a possible target for new therapeutic strategies. VNS 
therapy has been successfully adopted for the treatment 
of drug-resistant epilepsy and depression (Ondicova et 
al. 2010; Groves & Brown 2005). It has also been under 
investigation for the management of various anxiety 
disorders (Groves & Brown 2005), Alzheimer’s disease, 
migraines (Cecchini et al. 2009), fibromyalgia (Finocchi 
et al. 2010), and tinnitus (Engineer et al. 2011). More-
over, stimulation of the vagus nerve increases the pro-
duction of anti-inflammatory cytokines and thus may 
lead to the increased rate of survival in experimental 
sepsis, hemorrhagic shock and ischemia–reperfusion 
injury models (Johnston & Webster 2009; Mihaylova et 
al. 2012; Hiraki et al. 2012). In such vagus nerve manip-
ulations, it has been surprisingly discovered, that VNS 
therapy induces alterations in food intake and weight 
decrease. This fact has encouraged us to investigate 
the possible mechanisms of the weight loss after vagus 
nerve stimulation.
We presumed that VNS decreases food intake and 
body weight gain by “mimicking” satiety signals trans-
mitted from the gut to the brain, leading to the activa-
tion of the hypothalamic neurons resulting in achieving 
the state of satiety. Because vagal afferents project to 
second order neurons in the nucleus of the solitary tract, 
stimuli elicited by electrical pulses could rapidly change 
neural activity in the NTS to initiate hormonal changes, 
including the hypothalamic-pituitary-adrenal axis 
activation. We adopted an animal obesity model using 
high-fat diet (HFD), as obesity induced by high-fat diet 
mimics obesity in humans, and is widely considered 
as an appropriate model for studying dietary obesity 
(Hariri & Thibault 2010).
The first aim of this study was to test the hypoth-
esis, whether VNS increases the HPA activity, assessed 
by corticosterone levels measurements. Secondly, we 
examined the effects of VNS with low (1Hz) and high 
(10Hz) frequencies on corticosterone levels and behav-
ioral parameters of the rats (food intake, body weight 
gain and fat accumulation). Finally, we examined c-Fos 
positive neurons count in NTS following chronic elec-
trical vagus nerve stimulation. The c-fos belongs to the 
family of the immediate early genes and is expressed 
rapidly in the nodose ganglions and in the central ner-
vous system after various forms of stimulation, and thus 
the increase in c-Fos expression is now widely accepted 
as a marker of neuronal activity (Gil et al. 2011b; Hoff-
man & Lyo 2002).
MATERIAL AND METHODS 
The experiments were performed in two sets.
First experiment
Twenty-four male Wistar rats, housed in individual 
cages, were used in this experiment. All animals were fed 
a high-fat diet (caloric distribution of the diet: protein 
25.1%, fat 38.8%, carbohydrates 36.1%, metabolizable 
energy 4.34 kcal/g; Bento Kronen Products, Belgium) 
during the whole experiment. The temperature was 
maintained at 23±2 °C and animals were placed on a 
12:12 h dark/light cycle. Food and water were provided 
ad libitum. Jagiellonian University Bioethical Commit-
tee approved the care and use of the animals (protocol 
number – 36/2008). 
After 2 weeks of adaptation to the environmental 
conditions and fat diet rats were starved for 12 hours 
and operated under general anesthesia induced with 
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sodium pentobarbital given intraperitoneally (Vetbutal, 
0.25 mg/kg, Biowet, Pulawy, Poland). 
The rats were randomly divided into following 
groups: 1. rats with active microstimulator (MS) con-
nected by electrodes with the left vagal nerve (MS 1 Hz 
group, n=8); 2. animals with inactive MS without elec-
trodes on the vagal nerve (sham 1 Hz group, n=8), and 
3. intact rats – without MS and electrodes (control 1 Hz 
group, n=8). The control group of animals (intact rats) 
was included in the study to eliminate any effects of sur-
gical procedures on examined parameters, while sham 
operated group served as the most important reference 
group for the assessment of food intake, body weight, 
epididymal fat pad weight and corticosterone levels.
The MS for vagus chronic stimulation (designed 
by Institute of Electron Technology, Krakow, Poland) 
was placed during the surgery into the subcutaneous 
pocket and the ends of the MS silver electrodes were 
wrapped around the subdiaphragmatic left vagal nerve. 
Cathode and anode were positioned at 0.5 cm distance. 
In the second group, laparotomy was performed and 
inactive MS was implanted (sham group), while in the 
control group (intact) no surgical manipulations were 
performed. Food was restored the next day. After a one-
week recovery period rats were put into cages exposed 
to electromagnetic field and the stimulation started 
(day 1st) as described previously (Gil et al. 2011a). The 
animals from the MS and sham groups were placed 
individually into plastic cages and exposed to the mag-
netic field. The magnetic field served as an external 
source of current in the MS wires connected to the left 
vagus nerve. The parameters of the magnetic field were 
set experimentally, to match amplitude, duration and 
frequency of impulses used in our experiment. The 
third (control) group of rats was placed into cages out-
side the magnetic field. 
The parameters of the impulses generated by MS 
were based on our previous studies and set as follows: 
unipolar rectangular pulses, duration 10 ms, amplitude 
200 mV, frequency 1 Hz. The stimulation of animals 
started every day at 6 p.m. and lasted 12 h until 6 a.m. 
the next morning (dark phase stimulation).
Daily food intake and body weight were measured 
each morning during the entire study. The amount of 
daily food intake was determined by subtracting the 
amount of food remaining from the amount given 
24 h before. All the rats were killed by decapitation 
and weighted at the end of the experiment (day 42nd). 
Both epididymal fat pads, located between the cauda 
epididymis and the distal extremity of the testis, were 
dissected from the animal and weighted. 
Blood samples collected at the end of the experiment 
were taken into tubes filled with aprotinin (0.6 TIU 
per 1ml of blood; Sigma-Aldrich, USA), left for 30 
minutes for clotting formation and after centrifuga-
tion 1500 × g, 20 min at 4 °C (Megafuge 1.0R, Heraeus 
Instruments) serum samples were collected and frozen 
at –80 °C until further analysis. Glucose and hepatic 
enzymes (aspartate and alanine transaminases) were 
measured with chemistry immune-analyzer Olympus 
AU 600. Corticosterone serum levels were quantified 
by enzyme immunoassay method (EIA) according to 
the protocol provided by manufacturer (IDS Limited, 
Fountain Hills, AZ, USA). ELx800 Absorbance Micro-
plate Reader (Bio-Tek) was used for the absorbance 
detection. 
Second experiment
Twenty-four animals were fed high-fat diet and main-
tained in the same condition as described for the first 
experiment, while additional eight rats were fed the 
standard diet (caloric distribution of the standard diet 
was: protein 26.7%, fat 7.9%, carbohydrates 65.4%, 
metabolizable energy 2.86 kcal/g; Labofeed, Poland). 
This group of animals (standard group; without MS 
and electrodes) was included in the study, to compare 
the effects of high-fat diet on rats. The schema of the 
second experiment was similar to the first one, with the 
exception of the frequency of vagus nerve stimulation, 
which was set at 10 Hz. 
At the end of the second set of experiments, follow-
ing decapitation, the whole brain was removed from the 
skull and placed in a solution of 4% paraformaldehyde 
in 0.1 M phosphate buffer (pH 7.4) for 24 h. Activated 
neurons of the nucleus of the solitary tract (NTS) were 
visualized by immunochemistry method, according to 
the methodology previously described (Gil et al. 2011a), 
using primary polyclonal rabbit antibodies against 
c-Fos (Santa-Cruz, sc-52, diluted 1:200), using diami-
nobenzidine as a chromogen. The brown-stained cells 
stained were considered positive and analyzed using an 
AXIOPHOT light microscope (Zeiss, Germany).
Statistical analysis
Data are expressed as mean and standard deviation 
(SD), except for the corticosterone (standard error of 
mean – SEM). Results were analyzed by one-way analy-
sis of variance (ANOVA), followed by post-hoc LSD 
test with STATISTICA 8.0 software package (StatSoft, 
Tulsa). Statistical significance was set at p<0.05.
RESULTS
Food intake, body weight and epididymal fat pad weight
Food intake, body weight and epididymal fat pad 
weight are presented in Table 1 and Table 2. 
Peripheral electrical stimulation of the left vagal 
nerve reduced the daily and total food intake in MS 
1 Hz and MS 10 Hz groups compared to sham and 
control groups in both experiments and these differ-
ences were statistically significant. Moreover, VNS 
significantly reduced body weight gain in these groups 
as well. Fat pad weight reflecting total body fat content 
was significantly lower in both MS groups compared 
to relevant sham and control (intact) groups of rats 
(Table 1 and Table 2). 
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Blood biochemical analyses
There were no statistically significant differences 
between the VNS-treated rats and sham, control, as 
well as standard groups in the level of glycemia and in 
the levels of aspartate and alanine transaminases as well 
(Table 3). 
Corticosterone
Corticosterone serum levels were increased in stimu-
lated rats with both (1 Hz and 10 Hz) types of peripheral 
vagal stimulation. Vagus nerve stimulation with 10 Hz 
significantly elevated corticosterone serum levels com-
pared to other groups of animals (222.96±63.52 ng/mL 
in stimulated group, 71.27±23.68 ng/mL in sham group 
and 46.58±26.66 ng/mL in control group, respec-
tively; Figure 1). Vagus nerve stimulation (1 Hz) 
increased corticosterone serum levels, though not 
significantly, compared to sham 1 Hz and control 
1 Hz groups (141.58±52.58 ng/mL in stimulated 
group, 73.18±27.87 ng/mL in sham group, and 
48.31±10.64 ng/mL in control group, respectively; 
Figure 1). It appeared that the stimulation with higher 
frequency evoked stronger response of the hypotha-
lamic-pituitary-adrenal axis. No differences were found 
between relevant sham and control groups as well as 
standard group (Figure 1).
Activated neurons in the nucleus of the solitary tract
c-Fos–positive neurons in the NTS were found in all of 
the rat brain hemisections examined. The amounts of 
c-Fos positive cells were similar in the NTS in the con-
trol, sham and standard groups. However, the number 
of c-Fos-positive cells increased significantly (p<0.01) 
above basal levels following left vagus nerve stimulation 
with 10 Hz frequency (Figure 2). 
Tab. 1. Mean food intake, body weight and epididymal fat pad weight in MS left vagus nerve stimulation (1Hz), sham operated, and control 
(intact) rats. 
First experiment Sham MS–1Hz Control
Food intake during experiment (g) 1025±65 891±89* 1042±78
Initial body weight  (g) – day 1 498.5±33.1 501.9±27.1 509.1±45.1
Final body weight (g) – day 42 673.5±38.4 641.7±31 687.5±44.5
Body weight gain (g) 166.2±21 136.9±8.9* 162.8±43.4
Body weight gain increment over initial body weight (%) 33.5 27.9* 32.3
Epididymal fat pad weight (g) 13.7±3.4 11.8±1.5* 14.7±4.7
Asterisks (*) indicate significant differences between MS–1Hz group and sham and control group. 
Tab. 2. Mean food intake, body weight and epididymal fat pad weight in MS left vagus nerve stimulation (10Hz), sham operated, control 
(intact), and standard rats.
Second experiment Sham MS–10 Hz Control Standard
Food intake during experiment (g) 990±56 878±89* 1011±65 1210±89
Initial body weight  (g) – day 1 467.3±25.1 470.1±26.7 478.7±23.8 526.5±25.2
Final body weight (g) – day 42 607.9±44.5 577.9±55.3* 612.7±49.5 629±22.7
Body weight gain (g) 140.6±37.8 111.8±36.1* 134.1±36.7 111.3±19.5
Body weight gain increment over initial body weight (%) 30.2 22.7* 28.9 20.8
Epididymal fat pad weight (g) 11.1±2.8 9.0±1.7* 10.5±2.7 9.3±2.6
Asterisks (*) indicate significant differences between MS–10Hz group and sham and control group. 
Tab. 3. Blood serum levels of glucose (mmol/L), as well as aspartate (AspAT) and alanine (AlAT) transaminases (UI/L) in MS left vagus nerve 
stimulation (1 Hz and 10 Hz), sham operated, control (intact), and standard rats. 
Group
1 Hz experiment 10 Hz experiment 
Sham MS–1 Hz Control Sham MS–10 Hz Control Standard
Glucose 7.71±0.49 7.72±0.42 8.11±0.69 7.14±0.47 6.91±0.67 6.8±0.84 7.37±1.11
AspAT 153±19 186±17 160±28 185±32 185±42 195±40 170±53
AlAT 68±10 60±7 65±11 52±7 56±5 60±9 67±17
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DISCUSSION
In current study we evaluated effects of VNS on the 
basal activity of the hypothalamus-pituitary-adrenal-
axis in rats fed high-fat diet. The influence of HFD 
on the basal HPA activity has been previously exam-
ined. Analysis by Auvinen et al. (2011) revealed, at 
least in mice models, conflicting results with respect 
to the hypothalamus-pituitary-adrenal-axis activation 
by high-fat diets. Plasma corticosterone levels were 
unchanged in 40%, elevated in 30%, and decreased in 
20% of the studies examined. The effects in the periph-
eral tissues and the central nervous system were also 
inconsistent and major differences were found between 
mouse strains, experimental conditions, and the con-
tent and duration of the diets. This review demon-
strated that the effects of high fat feeding on the basal 
activity of the hypothalamus-pituitary-adrenal-axis are 
Fig. 1. Corticosterone serum 
concentration after left vagus nerve 
stimulation with the frequency of 
1 Hz (MS-1Hz), 10 Hz (MS-10 Hz) 
and relevant sham, control and 
standard groups (n=8 for each group). 
Corticosterone levels significantly 
elevated in MS-10 Hz and in the 
MS-1 Hz groups. Data are presented 
as mean and standard error of mean 
(SEM). * p<0.05 as compared to 
relevant sham and control group.
Fig. 2. The number of c-Fos 
immunopositive neurons in the 
nucleus of the solitary tract (NTS) after 
peripheral electrical stimulation of the 
left vagus nerve with the frequency 
of 10 Hz. The significant increase of 
c-Fos positive neurons in the NTS of 
stimulated rats. Data are presented 
as the mean and standard deviation 
(SD); n=8 for each group. Asterisks 
(*) indicate significant differences 
between the MS-10Hz group and the 
sham, control and standard groups, 
respectively. 
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limited and inconclusive. Our experiment did not reveal 
significant changes in corticosterone levels caused by 
high-fat diet. Tannenbaum et al. (1997) reported an 
elevation of corticosterone concentrations after fatty 
diet in rats. In terms of HPA activity, increased fat con-
sumption appeared to function as a chronic stressor. As 
in other chronic stress models, there appeared to be a 
small amount of adaptation to high-fat feeding. After 
12 weeks of exposure to high fat, animals failed to show 
a significantly elevated basal corticosterone levels com-
pared with controls. 
Conversely, it has also been demonstrated that food 
deprivation markedly elevates the plasma level of corti-
costerone. Park et al. (2004) described elevated serum 
corticosterone concentrations in response to fasting in 
both fasted normal and spontaneous dwarf male rat. 
Chang et al. (2002) reported similar results in ovariec-
tomized rats. Food restriction induced higher corticos-
terone plasma concentration through enhanced ACTH 
release. Additional data came from studies by Timofe-
eva et al. (2002), Jahng et al. (2005) and by Chmielowska 
et al. (2011). These data suggest that the responsivity of 
the HPA axis either to fasting or high-fat feeding stress-
ors results in increasing corticosterone release.
Since VN participates in the HPA activation, and 
high-fat diet as well as food deprivation both increase 
corticosterone levels, it seems reasonable to assume, 
that when VN integrity is disturbed, the release of 
ACTH and corticosterone should be blocked. The 
experiments with vagotomy, however, brought confus-
ing results. Kessler et al. (2012) examined serum levels 
of corticosterone in sepsis in mice. Vagotomy in the 
non-septic organism does not influence the corticoste-
rone level. In the study by Bugajski et al. (2007) sub-
diaphragmatic vagotomy or sham vagotomy itself did 
not substantially alter the resting plasma ACTH and 
serum corticosterone levels, measured 2 weeks after 
surgery, but reduced ACTH and corticosterone secre-
tion and brain norepinephrine changes that follow the 
intraperitoneal administration of LPS and IL-1β after 
subdiaphragmatic vagotomy in Wistar rats. This obser-
vation was in agreement with other reports by Hansen 
et al. (2000) after intraperitoneal lipopolysaccharide 
administration and by Arnhold et al. (2009) in water-
restricted rats. These data indicate that an intact vagus 
is necessary to proper responses of HPA axis to stress 
factors. It should be also mentioned here, that in our 
experiments rats were kept in single cages, what could 
be considered as such stress factor and thus may influ-
ence the HPA axis tonicity (Bugajski et al. 2004). Such 
study design, however, allowed us to assess the amount 
of food consumed separately by each animal. Secondly, 
all animals were treated similarly, and thirdly, the VNS 
protocols lasted 6 weeks, and such long time supposed 
to be adequate to develop the appropriate adaptation. 
In current study chronic vagus nerve stimulation 
significantly decreased food intake, body weight gain 
and epididymal fat pad weight in stimulated animals 
compared to control animals in both experiments with 
1 Hz and 10 Hz VNS frequencies. Moreover, stronger 
effect of VNS with 10 Hz stimulation rate on such 
behavioral parameters has been noted. These data are 
consistent with previously reported results from experi-
ments done in rats fed the standard diet (Bugajski et al. 
2007), and further, following left VNS with 10Hz fre-
quency in rats fed a high-fat diet (Gil et al. 2011a, b). 
Multiple animal models proved the efficacy of VNS in 
weight loss, whereas clinical studies are so far inconclu-
sive (see review Bugajski & Gil 2012). 
I has been reported, that VNS is involved in activa-
tion of the hypothalamic-pituitary-adrenal axis. This 
was demonstrated by VNS-induced increased hippo-
campal expression of corticotrophin releasing factor 
and increased plasma levels of adrenocorticotropic 
hormone and corticosterone after VNS by Hosoi et al. 
(2000) and de Herdt et al. (2009). In the study by Hosoi 
et al. (2000) direct electrical stimulation of the central 
end of the vagus nerve performed continuously for 2 h. 
induced increases in the expression of corticotrophin 
releasing factor mRNA in the hypothalamus. Further-
more, plasma levels of ACTH and corticosterone were 
also increased by this stimulation. This first report 
indicating that activation of the afferent vagus nerves 
itself can activate the HPA axis was consequently sup-
ported by work from O’Keane et al. (2005), performed 
in group of patients with chronic depression. Chronic 
depression increased ACTH response to CRH chal-
lenge. Short-term treatment with VNS therapy was 
associated with normalization of this response. Fur-
thermore, De Herdt et al. (2009) investigated the effects 
of VNS on serum corticosterone levels following 1 h of 
high frequency (30 Hz) or low frequency (1 Hz) VNS 
in awake animals. He reported significant increase 
in serum corticosterone levels following 30 Hz VNS 
compared to 1 Hz VNS or sham stimulation. Recently 
Thrivikraman et al. (2012) in rats examined the left cer-
vical VNS with current pulses set at 20 Hz. Acute VNS 
increased HPA axis activity, as well as c-Fos positive 
neurons count in NTS, with tendency toward recovery 
to baseline in animals treated by chronic VNS. These 
results suggest an immediate effect of VNS on the 
hypothalamic pituitary-adrenal (HPA) axis and sup-
port the role of the vagal nerve in immunomodulation 
as well as in maintaining organism’s homeostasis. So 
far, there was lack of reports, either clinical or experi-
mental, reviewing VNS related to HPA activity in 
connection to obesity. In current study we have found 
elevated basal corticosterone serum levels in stimu-
lated rats with both (10 Hz and 1 Hz) types of periph-
eral vagal stimulation compared to sham and control 
groups. Noteworthy, it appeared that the stimulation 
with higher frequency evoked stronger response of the 
hypothalamic-pituitary-adrenal axis. 
The VNS in the possibly new therapies has 
been extensively studied, including animal models. 
Although exact mechanisms of VNS central action 
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remain unclear, few possibilities have been discussed 
(Aalbers et al. 2011). All postulated mechanisms prove, 
that NTS neurons activation is the key factor in mech-
anism involving peripheral vagus nerve stimulation. 
The question arises, how to set – up the VNS param-
eters, to treat the patients in efficient, but concurrently 
safe way. 
This issue was intensely discussed by Bonaz et al. 
(2013). It was firstly hypothesized that vagus nerve 
stimulation at high frequency (20–30 Hz) acts mainly 
on vagal afferents and thus is useful for the treatment of 
drug-resistant epilepsy and depression, while the low-
frequency (less than 5 Hz) VNS targets predominantly 
vagal efferents and evokes anti-inflammatory effects 
(known as CAP – anti-inflammatory pathway). More-
over, the frequency significantly higher than 50 Hz was 
shown to be ineffective, possibly causing disruption of 
electrical properties vagal fibers and leading to its irre-
versible injury (Merrill et al. 2005). 
Osharina et al. (2006) performed VNS of the central 
cut left VN. They showed a gradual increase in c-Fos 
expression in the brain of animals with VNS from 1 to 
10 Hz; 1 Hz VNS only discretely affected the level of 
c-Fos expression in the NTS, compared to sham-oper-
ation, while in contrast, c-Fos expression was mark-
edly above sham-operation levels in the NTS following 
10 Hz stimulation. The first fMRI (functional magnetic 
resonance imaging) study of acute (1 h) VNS in anes-
thetized rodents revealed, that VNS at low-frequency 
stimulation (5 Hz), is also able to activate the brain neu-
rons (Reyt et al. 2010). Thus, considering our results, 
we conclude, that left VNS with either lower (1 Hz) or 
higher (10 Hz) frequency is capable to influence the 
brain centers, but VNS with higher frequency seems to 
be more efficient in modulations of NTS neurons and 
HPA activation.
Finally, we wondered, whether peripheral VNS 
applied in our study was sufficient to influence brain 
circuits, imitating the satiety signals originating from 
the gut to the CNS, and thus, leading to decrease in food 
consumption and body mass reduction. Consequently, 
since the cell bodies of the vagal visceral afferents are 
contained within the nodose ganglions, and the cen-
tral terminals of the primary vagal afferents are mainly 
found in the nucleus of the solitary tract, an increase 
in c-Fos positive neurons in the NTS may confirm our 
VNS to be efficient. Indeed, in the present study we 
revealed a significant response in the NTS following 
left vagus nerve stimulation. These findings along with 
previously published data (Gil et al. 2011b) on the pres-
ence of multiple c-Fos positive neurons in the nodose 
ganglions of stimulated rats indicate, that VNS evoked 
a response in the appetite-related neural centers.
The electrical peripheral stimulation of vagal affer-
ents is the area of interest in the experimental and 
clinical obesity management. One of the possible 
mechanisms of VNS actions includes neuroendocrine 
modulation of the HPA axis.
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